Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Relzomostat

Inquiry
Cat. No.: OB0425LY-027
Synonyms: Relzomostat [INN]; 2081078-92-2; 2,6-Diazaspiro(3.3)heptane-2-carboxylic acid, 6-(2,2-difluoroethyl)-, (3R,4S,5S,6R)-5-Methoxy-4-((2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl)-1-oxaspiro(2.5)oct-6-yl ester
Size: 50 mg; 100 mg; 250 mg
CAS No.: 2081078-92-2
Compound CID: 146014918
Relzomostat

Specification

Description: Relzomostat is a potent inhibitor of methionine aminopeptidase 2 (MetAP2).
Formula Weight: 470.55
Applications: Relzomostat can be used for research on obesity, type 2 diabetes and other obesity-related diseases.
Storage: Storage at -20°C.
Formula: C24H36F2N2O5
Appearance: Solid
Purity: ≥95%
Pathway: Metabolic enzyme/Protease
Target: MetAP

Library Information

Inquiry

Copyright © Protheragen. All rights reserves.